Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.068 AUD | +4.62% | +4.62% | -28.42% |
May. 08 | Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13% | MT |
Apr. 16 | Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.42% | 5.13M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ILA Stock
- News Island Pharmaceuticals Limited
- US FDA Places Island Pharmaceuticals' Phase 2A Clinical Trial for Dengue Treatment Under Clinical Hold